The same research group also developed a high-throughput screening method that distinguishes ovarian cancer patients with a high degree of accuracy by targeting epithelial cell adhesion molecule (EpCAM) and CD24 on EVs in ascites [59]. Here, EPCAM is linked to ovarian cancer.